LMG Life Sciences Awards EMEA 2022: open for submissions

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2022: open for submissions

lmg-life-sciences-awards-for-dat-600x400-emea.png

The EMEA region research cycle has commenced – do not miss the opportunity to nominate your work from 2021

The LMG Life Sciences Awards team is excited to announce the launch of the 2022 research. You can find more about the awards, including the methodology, FAQs, and the full list of categories at the LMG Life Sciences website.

2022 calendar:

  • Research launches: December 9 2021

  • Submissions deadline: January 27 2022

  • Research interviews: February 1 to March 18 2022

  • Awards ceremony: May 12 2022

All submissions must be uploaded here by January 27 2022.

For any questions about the awards or the research, please contact the lead researcher, John Harrison.

For queries about business development and commercial opportunities related to the awards, please contact Nick Heath.

Last year’s LMG Life Sciences Awards winners’ presentation and lists are free to view at Winners 2021.

Good luck to everyone!

more from across site and SHARED ros bottom lb

More from across our site

Arrival of Laura Alsonso, alongside a team of 11, will bring ‘significant value’ to ECIJA clients, says CEO
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Gift this article